About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Investor Centre
- Investor Centre
- News & ASX Announcements
Contact

Hit enter to search or ESC to close

Phosphagenics Announces Transition of Chairman of Board

April 21, 2017

Click here to read more

Post navigation

Phosphagenics Participation in ‘New Innovations in Drug Delivery Technology’ Webcast

Phosphagenics Notice of Annual General Meeting

Related Posts

Phosphagenics Initiates Arbitration Against Mylan

January 7, 2016

Phosphagenics Newsletter July 2015

July 9, 2015

2016 Aug 31 Phosphagenics Poultry Feed Efficiency Study

August 31, 2016

Recent Posts

Avecho investor update – webinar recording
June 25, 2020
Ashland Purchases Manufacturing Rights for VitalET and TPM
June 20, 2019
Change of Company Name and ASX Code
May 24, 2019

Categories

Analyst Coverage
Company Announcement
Company Report
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- News & ASX Announcements

© Copyright 2019 Avecho Biotechnology Ltd.